HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical efficacy of rubella vaccine.

Abstract
In the period October 10, 1980, to January 19, 1981, 83 cases of rash illness compatible with rubella were reported in Sanford, ME. Twenty-two (27%) were confirmed serologically. Forty cases (48%) occurred in Sanford High School students; the overall attack rate was 3.2%. A case-control study was undertaken to determine the effectiveness of rubella vaccine in preventing clinical rubella. Bayes' theorem was used to calculate the attack rates in the vaccinated population (ARV) and the unvaccinated population (ARU). Vaccine efficacy (VE), calculated with use of the formula VE (%) = [(ARU - ARV)/ARU] x 100, was 90%. These results indicate that rubella vaccine is highly effective in preventing clinical rubella and do not support proposals for routine revaccination.
AuthorsW L Greaves, W A Orenstein, A R Hinman, W S Nersesian
JournalPediatric infectious disease (Pediatr Infect Dis) 1983 Jul-Aug Vol. 2 Issue 4 Pg. 284-6 ISSN: 0277-9730 [Print] United States
PMID6889155 (Publication Type: Journal Article)
Chemical References
  • Rubella Vaccine
Topics
  • Adolescent
  • Adult
  • Bayes Theorem
  • Child
  • Child, Preschool
  • Disease Outbreaks (epidemiology, prevention & control)
  • Female
  • Humans
  • Infant
  • Maine
  • Male
  • Middle Aged
  • Rubella (epidemiology, prevention & control)
  • Rubella Vaccine (administration & dosage)
  • Vaccination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: